瘤联合药物开发策略 项目最佳的项目
Timothy A Yap1, Julie Bullock2, Susan Chong3
1The University of Texas MD Anderson Cancer Center, Houston, Texas.
概括
项目Optimus通过优化单个药物的剂量来指导瘤药物开发. 组合药物开发需要逐个案例的方法,整合所有可用的证据,以制定有效的策略.
科学领域:
- 瘤学 药物开发 药物开发
- 药理学 药理学是指药理学的学科.
- 监管科学 监管科学
背景情况:
- 美国食品和药物管理局 (FDA) 推出了"最佳项目",以改进癌症药物开发中的剂量优化和选择.
- 现有的FDA指南主要针对单个瘤药物的剂量优化.
- 对于联合瘤学药物开发战略的需求越来越大.
研究的目的:
- 概述开发组合性瘤治疗方案的赞助商和研究人员的关键考虑因素.
- 在复杂的组合药物开发环境中提出剂量优化策略.
- 通过与典型药物开发场景相关的假设案例提供指导.
主要方法:
- 审查FDA的Project Optimus倡议和现有的指导.
- 分析组合药物开发剂量优化的复杂性.
- 开发假设案例示例,说明剂量优化策略.
- 强调整合各种数据:作用机制,非临床和临床药理学,安全性和基于模型的药物开发原则.
主要成果:
- 组合瘤治疗的剂量优化是复杂的,需要一个量身定制的,个别案例的方法.
- 充分利用全部证据的综合方法至关重要.
- 假设的案例示例展示了战略的实际应用.
结论:
- 与监管机构的密切合作和讨论对于在联合瘤学药物开发中导航剂量优化至关重要.
- 赞助商和调查人员必须采用灵活,基于证据的方法.
- 这些发现旨在支持开发有效和安全的组合癌症疗法.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
01:21Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K